SPOTLIGHT: Regeneron wins FDA approval


The FDA has approved Regeneron's Arcalyst for two rare inflammatory diseases. The ailments are known as cryopyrin-associated periodic syndromes, which can cause pain, fever and hearing loss. Some 300 people in the U.S. suffer from these conditions. Release

Suggested Articles

LianBio aims to bring much-needed new drugs to China and serve as a partner for U.S. biotechs looking to expand into Asia.

Despite the setback, Fulcrum hailed the data as “very encouraging,” zeroing in on results from a pre-specified sensitivity analysis to make its case.

Bayer has struck a $425 million upfront deal to buy KaNDy in the belief its treatment for menopause-related hot flashes has blockbuster potential.